Blood Thinners Faq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Comments
On Thursday, 11 March, Norway, Denmark and some other European countries suspended the use of the Oxford-AstraZeneca COVID vaccine post reports of blood clotting in some vaccine recipients. There were also reports that a 50-year-old man had died in Italy after developing deep vein thrombosis (DVT) following a dose of the jab.
However, the EU s medicines regulator said that there is no indication that the vaccine is linked to an increased risk of blood clots, reported
IANS. It said the number of cases in vaccinated people was no higher than in the general population.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. The vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing,”European Medicines Agency (EMA) said on Thursday, 11 March. ....

United Kingdom , Pramod Kumar , Phil Bryan , Regulatory Agency , Should India , Eu Astrazeneca , European Union , Co Vid , Covid Vaccine , Blood Thinners , Blood Thinners Faq , Blood Clot , Astrazeneca Blood Clots , Astrazeneca Vaccine Blood Clot , Denmark Suspends Astrazeneca , Covid 19 Vaccine , Corona Vaccine , Oxford Astrazeneca , ஒன்றுபட்டது கிஂக்டம் , பிரமோத் குமார் , பில் பிரையன் , வேண்டும் இந்தியா , ஐரோப்பிய தொழிற்சங்கம் , இணை வித் , இரத்தம் உறைதல் , கொரோனா தடுப்பூசி ,